Cannabinoid Therapy Formulations for Sleep and Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for more effective and safer cannabis products for various medical uses, particularly in addressing sleep, pain, and anxiety conditions, as existing products often have limitations in efficacy and safety.
Innovation Solution
The development of cannabinoid therapy formulations comprising negative allosteric modulators of the cannabinoid receptor 1 (CB1), partial agonists, CB1 antagonists or negative allosteric modulators, gamma-aminobutyric acid (GABA)A receptor activators, and transient receptor potential cation channel, subfamily A, member 1 (TRPA1) activators, in specific ratios and combinations, along with other botanicals, to target the endocannabinoid system for improved therapeutic outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single cannabinoid products are used, then simplicity of product formulation is maintained, but therapeutic efficacy is limited
Solution Approach 1:
The patent combines multiple cannabinoids (CBD, CBN, CBG) in specific ratios within a single product formulation to achieve synergistic therapeutic effects. This merging of multiple active ingredients resolves the contradiction by improving efficacy through combination while maintaining product simplicity through integrated formulation.
Solution Approach 2:
The invention creates composite cannabinoid formulations with specific ratios of different cannabinoids (e.g., CBD:CBN:CBG = 2:1:1 or 3:1:1). These composite materials provide enhanced therapeutic efficacy compared to single cannabinoids, resolving the contradiction between simplicity and effectiveness.
2Reliability
If higher doses of cannabinoids are administered, then therapeutic outcomes are improved, but adverse events increase
Solution Approach 1:
The patent optimizes the dosage parameters of individual cannabinoids within the combination. By adjusting the ratios and doses of CBD, CBN, and CBG to specific ranges, the formulation achieves therapeutic outcomes at lower total doses compared to single cannabinoid products, thereby reducing adverse events while maintaining efficacy.
Solution Approach 2:
The invention uses lower doses of multiple cannabinoids to achieve the same or better therapeutic effects compared to high doses of single cannabinoids. This converts the potential harm of high dosing into the benefit of reduced side effects while maintaining or improving therapeutic outcomes through synergistic combination.
3Reliability
If existing cannabis products are used, then availability is maintained, but safety is compromised
Solution Approach 1:
The patent creates specialized cannabinoid formulations tailored to specific therapeutic conditions (sleep, pain, anxiety) with optimized ratios of CBD, CBN, and CBG. This local quality approach improves safety and effectiveness for specific conditions rather than using generic cannabis products for all purposes.
Data Source
AI summary
Described herein are cannabinoid therapy formulations for sleep, pain, and anxiety conditions. Also provided are methods for improving sleep quality, relieving pain and/or improving anxiety symptoms.


